The prestigious award recognises Professor Chris Goodnow's innovative work on immune tolerance and chronic disease.Professor ...

AbbVie said on Monday it would acquire privately held cell therapy developer Capstan Therapeutics in a deal worth up to $2.1 ...

AbbVie is acquiring Capstan Therapeutics, a startup with technology that enables in vivo engineering of immune cells.

An engineered protein turns off the kind of immune cells most likely to damage tissue as part of type 1 diabetes, hepatitis ...

AbbVie ABBV announced that it has entered into a definitive agreement to acquire privately held biotech, Capstan Therapeutics ...

AbbVie has agreed to buy Capstan Therapeutics for up to $2.1 billion, expanding its pipeline with a potential first-in-class ...

在医学科研的前沿阵地，澳大利亚科研团队在 Cellular&Molecular Immunology 期刊上发表了一篇题为 “Adjusting the scope of natural killer cells in cancer therapy” ...

In the fight against cancer, immunotherapy—which aims to boost the body's natural defenses against cancer—is experiencing ...

Cancer: «forgotten» cells go on the offensive. UNIGE Immunologists have discovered the yet unsuspected anti-tumour potential ...

Advanced imaging technologies are uncovering surprising roles for CD8+ T cells—not just in immune defense, but also in supporting tissue repair and regeneration.

Northwestern Medicine investigators have identified a surprising culprit in the progression of inflammatory bowel disease: a ...

LJI scientists have discovered that T cells may help detect Parkinson's disease years before motor symptoms appear. Your T ...